Discover
RLAY
Relay Therapeutics, Inc.
17.88
2 x 14.35
2 x 24.83
bid
ask
+
0.47
2.70%
2 @ 05:02 AM
17.93 +0.05 (0.28%)
| Ytd | 111.35% | |
| 1y | 175.08% |
17.30
day range
18.50
5.85
52 week range
21.27
| Open | 17.44 | Prev Close | 17.41 | Low | 17.30 | High | 18.50 | Mkt Cap | 3.92B |
| Vol | 1.76M | Avg Vol | 2.78M | EPS | -1.56 | P/E | N/A | Forward P/E | -10.95 |
| Beta | 1.72 | Short Ratio | 15.30 | Inst. Own | 110.87% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 11-05 | 50-d Avg | 19.06 | 200-d Avg | 14.26 | 1yr Est | 27.58 |
RLAY News
defenseworld.net
Financial Review: Relay Therapeutics (NASDAQ:RLAY) & BioMarin Pharmaceutical (NASDAQ:BMRN)
Relay Therapeutics (NASDAQ: RLAY - Get Free Report) and BioMarin Pharmaceutical (NASDAQ: BMRN - Get
defenseworld.net
Relay Therapeutics (NASDAQ:RLAY) CEO Sells $872,401.90 in Stock
Relay Therapeutics, Inc. (NASDAQ: RLAY - Get Free Report) CEO Sanjiv Patel sold 48,199 shares of Rel